vs
Side-by-side financial comparison of AMN HEALTHCARE SERVICES INC (AMN) and Dolby Laboratories, Inc. (DLB). Click either name above to swap in a different company.
AMN HEALTHCARE SERVICES INC is the larger business by last-quarter revenue ($748.2M vs $395.6M, roughly 1.9× Dolby Laboratories, Inc.). Dolby Laboratories, Inc. runs the higher net margin — 24.0% vs -1.0%, a 25.0% gap on every dollar of revenue. On growth, Dolby Laboratories, Inc. posted the faster year-over-year revenue change (7.1% vs 1.8%). Over the past eight quarters, Dolby Laboratories, Inc.'s revenue compounded faster (13.9% CAGR vs -4.5%).
AMN Healthcare Services Inc. is a leading US healthcare sector workforce solutions and staffing provider. It offers temporary and permanent placement for nurses, physicians, allied health and other clinical/non-clinical staff, plus workforce management tools and consulting for hospitals, clinics and other medical facilities.
Dolby Laboratories, Inc. is an American technology corporation specializing in audio noise reduction, audio encoding/compression, spatial audio, and high-dynamic-range television (HDR) imaging. Dolby licenses its technologies to consumer electronics manufacturers.
AMN vs DLB — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $748.2M | $395.6M |
| Net Profit | $-7.7M | $94.9M |
| Gross Margin | 26.1% | 88.7% |
| Operating Margin | 1.1% | 28.5% |
| Net Margin | -1.0% | 24.0% |
| Revenue YoY | 1.8% | 7.1% |
| Net Profit YoY | 95.9% | 3.4% |
| EPS (diluted) | $-0.19 | $0.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 26 | — | $395.6M | ||
| Q1 26 | — | $346.7M | ||
| Q4 25 | $748.2M | $346.7M | ||
| Q3 25 | $634.5M | $307.0M | ||
| Q2 25 | $658.2M | $315.5M | ||
| Q1 25 | $689.5M | $369.6M | ||
| Q4 24 | $734.7M | $357.0M | ||
| Q3 24 | $687.5M | $304.8M |
| Q2 26 | — | $94.9M | ||
| Q1 26 | — | $53.3M | ||
| Q4 25 | $-7.7M | $53.3M | ||
| Q3 25 | $29.3M | $49.3M | ||
| Q2 25 | $-116.2M | $46.1M | ||
| Q1 25 | $-1.1M | $91.8M | ||
| Q4 24 | $-187.5M | $67.8M | ||
| Q3 24 | $7.0M | $58.6M |
| Q2 26 | — | 88.7% | ||
| Q1 26 | — | 87.5% | ||
| Q4 25 | 26.1% | 87.5% | ||
| Q3 25 | 29.1% | 87.1% | ||
| Q2 25 | 29.8% | 86.1% | ||
| Q1 25 | 28.7% | 90.3% | ||
| Q4 24 | 29.8% | 88.6% | ||
| Q3 24 | 31.0% | 88.8% |
| Q2 26 | — | 28.5% | ||
| Q1 26 | — | 17.9% | ||
| Q4 25 | 1.1% | 17.9% | ||
| Q3 25 | 7.5% | 9.7% | ||
| Q2 25 | -18.8% | 15.1% | ||
| Q1 25 | 1.8% | 29.2% | ||
| Q4 24 | -27.6% | 22.4% | ||
| Q3 24 | 3.2% | 15.2% |
| Q2 26 | — | 24.0% | ||
| Q1 26 | — | 15.4% | ||
| Q4 25 | -1.0% | 15.4% | ||
| Q3 25 | 4.6% | 16.1% | ||
| Q2 25 | -17.7% | 14.6% | ||
| Q1 25 | -0.2% | 24.8% | ||
| Q4 24 | -25.5% | 19.0% | ||
| Q3 24 | 1.0% | 19.2% |
| Q2 26 | — | $0.99 | ||
| Q1 26 | — | $0.55 | ||
| Q4 25 | $-0.19 | $0.55 | ||
| Q3 25 | $0.76 | $0.50 | ||
| Q2 25 | $-3.02 | $0.48 | ||
| Q1 25 | $-0.03 | $0.94 | ||
| Q4 24 | $-4.90 | $0.70 | ||
| Q3 24 | $0.18 | $0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.0M | $594.7M |
| Total DebtLower is stronger | $767.1M | — |
| Stockholders' EquityBook value | $642.1M | $2.6B |
| Total Assets | $2.1B | $3.2B |
| Debt / EquityLower = less leverage | 1.19× | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | $594.7M | ||
| Q1 26 | — | $644.6M | ||
| Q4 25 | $34.0M | $644.6M | ||
| Q3 25 | $52.6M | $702.6M | ||
| Q2 25 | $41.5M | $699.3M | ||
| Q1 25 | $55.8M | $626.6M | ||
| Q4 24 | $10.6M | $520.8M | ||
| Q3 24 | $30.6M | $482.0M |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $767.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | — | — |
| Q2 26 | — | $2.6B | ||
| Q1 26 | — | $2.6B | ||
| Q4 25 | $642.1M | $2.6B | ||
| Q3 25 | $644.4M | $2.6B | ||
| Q2 25 | $607.6M | $2.6B | ||
| Q1 25 | $715.1M | $2.6B | ||
| Q4 24 | $706.6M | $2.5B | ||
| Q3 24 | $890.7M | $2.5B |
| Q2 26 | — | $3.2B | ||
| Q1 26 | — | $3.2B | ||
| Q4 25 | $2.1B | $3.2B | ||
| Q3 25 | $2.1B | $3.2B | ||
| Q2 25 | $2.2B | $3.2B | ||
| Q1 25 | $2.4B | $3.2B | ||
| Q4 24 | $2.4B | $3.2B | ||
| Q3 24 | $2.7B | $3.1B |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.19× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.6M | $147.3M |
| Free Cash FlowOCF − Capex | $67.6M | — |
| FCF MarginFCF / Revenue | 9.0% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | — | 1.55× |
| TTM Free Cash FlowTrailing 4 quarters | $233.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | $147.3M | ||
| Q1 26 | — | $54.8M | ||
| Q4 25 | $75.6M | $54.8M | ||
| Q3 25 | $22.7M | $472.2M | ||
| Q2 25 | $78.5M | $67.7M | ||
| Q1 25 | $92.7M | $174.9M | ||
| Q4 24 | $72.8M | $106.8M | ||
| Q3 24 | $66.7M | $327.3M |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $67.6M | $50.2M | ||
| Q3 25 | $14.8M | $435.9M | ||
| Q2 25 | $68.7M | $61.3M | ||
| Q1 25 | $82.7M | $168.0M | ||
| Q4 24 | $56.6M | $100.0M | ||
| Q3 24 | $47.4M | $297.2M |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 9.0% | 14.5% | ||
| Q3 25 | 2.3% | 142.0% | ||
| Q2 25 | 10.4% | 19.4% | ||
| Q1 25 | 12.0% | 45.5% | ||
| Q4 24 | 7.7% | 28.0% | ||
| Q3 24 | 6.9% | 97.5% |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | 1.3% | ||
| Q3 25 | 1.2% | 11.8% | ||
| Q2 25 | 1.5% | 2.0% | ||
| Q1 25 | 1.4% | 1.9% | ||
| Q4 24 | 2.2% | 1.9% | ||
| Q3 24 | 2.8% | 9.8% |
| Q2 26 | — | 1.55× | ||
| Q1 26 | — | 1.03× | ||
| Q4 25 | — | 1.03× | ||
| Q3 25 | 0.77× | 9.57× | ||
| Q2 25 | — | 1.47× | ||
| Q1 25 | — | 1.91× | ||
| Q4 24 | — | 1.57× | ||
| Q3 24 | 9.54× | 5.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMN
| Travel Nurse Staffing | $208.3M | 28% |
| Allied Staffing | $146.9M | 20% |
| Labor Disruption Services | $124.3M | 17% |
| Technology And Workforce Solutions | $88.0M | 12% |
| Language Services | $69.9M | 9% |
| Other | $29.6M | 4% |
| International Nurse Staffing | $29.6M | 4% |
| Interim Leadership Staffing | $24.1M | 3% |
| Vendor Management Systems | $16.3M | 2% |
| Local Staffing | $8.6M | 1% |
| International Nurse Permanent Placement | $2.6M | 0% |
DLB
| Licensing | $372.2M | 94% |
| Products and services | $23.4M | 6% |
